Advanced search
Instruments
Name | Stock exchange | Average volume | Price | Type | ||
---|---|---|---|---|---|---|
JOSHUA GOLD RESOURCES INC. | JSHG | OTC Markets | 111,540 | 0.01 USD | Stock |
News (64)
Companies (2)
Joshua Gold Resources Inc. is a Canada-based gold and mineral exploration company. The Companyâs principal business activity is the acquisition, exploration and development of mineral property interests in Canada. Its projects include Benoit-West, Carso ...
Top Ships Inc is a Greece-based international provider of worldwide oil, petroleum products, and chemicals transportation services. The Company owns and operates eco tanker vessels focusing on the transportation of crude oil, petroleum products (clean and ...
Insiders
Joshua Kazam currently works as a Director for 1685 38th REIT LLC.
Mr. Joshua A. Kazam is an Independent Director at Soaring Eagle Acquisition Corp., an Independent Director at Tishman Speyer Innovation Corp. II, an Independent Director at TS Innovation Acquisitions Corp., a Director & Partner at Vida Ventures LLC, a Partner at Two River Consulting LLC, a Director & Co-Owner at Riverbank Capital Securities, Inc., a Co-Founder & Partner at Two River Group Holdings LLC, a Co-Founder at VV Manager LLC, a Director & Vice President at Two River Group Management LLC, a Member-Executive Board at The Wharton School of the University of Pennsylvania and a Principal at BCIF Pty Ltd. He is on the Board of Directors at Soaring Eagle Acquisition Corp., Tishman Speyer Innovation Corp. II, TS Innovation Acquisitions Corp., Breakthrough Properties LLC, Breakthrough Services LLC, Allogene Therapeutics, Inc., Vida Ventures LLC, Kronos Bio, Inc., ByHeart, Inc., Desert Flower Foundation GmbH, Vision Path, Inc., MedPod, Inc., Veterinary Prime, Inc., Riverbank Capital Securities, Inc., 105 W First Street LLC, Cortiva Therapy, Danube Pharmaceuticals, Inc., Kirax Corp., Tranzutary Holdings LLC, Vetprime, Inc. and Two River Group Management LLC. Mr. Kazam was previously employed as an Independent Director by Flying Eagle Acquisition Corp., an Independent Director by Diamond Eagle Acquisition Corp., an Independent Director by Platinum Eagle Acquisition Corp., an Independent Director by Capricor Therapeutics, Inc., a Director-Investment Management by Orion Biomedical Fund LP, a Managing Director by Paramount BioCapital, Inc., and a Chief Executive Officer & Director by IconOVir Bio, Inc. He also served on the board at Kite Pharma, Inc., Velcera, Inc., Arno Therapeutics, Inc., Nile Therapeutics, Inc. /Old/, Arno Therapeutics, Inc. /Old/, Manhattan Pharmaceuticals, Inc. and Velcera Pharmaceuticals, Inc. /Old/. He received his undergraduate degree from The Wharton School of the University of Pennsylvania.
Mr. Noah Kazam, CFA, is an Associate at Kinderhook Partners LLC.
Prior to joining Kinderhook, Mr. Kazam was a member of MKF Capital Ltd, a New York based asset management firm where he most recently managed an equity portfolio of the firm's proprietary capital and made investments on behalf of the fund's external clients.
Mr. Kazam is a CFA charter holder and received a B.A.
in Italian from Middlebury College.
Joshua currently works at PT Fuji Finance Indonesia Tbk., as Head-Human Resources Development.
Mr. Joshua received his undergraduate degree from Monash University and undergraduate degree from Jakarta International College.
No results for this search
- Stock Market
- Advanced search
- Joshua Kazam